The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses
暂无分享,去创建一个
S. Nakae | M. Löhning | A. Hegazy | R. Klemenz | P. Fallon | K. Senn | H. Adler | D. Merkler | M. Kreutzfeldt | D. Pinschewer | A. Fröhlich | Weldy V. Bonilla | Susan Johnson | S. Kallert | Christina Schrick | Marylise Fernandez
[1] M. Larkum,et al. The Cellular Basis of GABAB-Mediated Interhemispheric Inhibition , 2012, Science.
[2] Xinchun Chen,et al. IL‐33 synergizes with TCR and IL‐12 signaling to promote the effector function of CD8+ T cells , 2011, European journal of immunology.
[3] R. Le Goffic,et al. Infection with influenza virus induces IL-33 in murine lungs. , 2011, American journal of respiratory cell and molecular biology.
[4] C. Gabay,et al. Interleukin-33 biology with potential insights into human diseases , 2011, Nature Reviews Rheumatology.
[5] E. Wherry,et al. Antiviral memory CD8 T-cell differentiation, maintenance, and secondary expansion occur independently of MyD88. , 2011, Blood.
[6] R. Medzhitov,et al. The control of adaptive immune responses by the innate immune system. , 2011, Advances in immunology.
[7] T. Abe,et al. IL-33 is a crucial amplifier of innate rather than acquired immunity , 2010, Proceedings of the National Academy of Sciences.
[8] Wei-hua Zhao,et al. The enigmatic processing and secretion of interleukin-33 , 2010, Cellular and Molecular Immunology.
[9] G. Nabel,et al. Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity , 2010, Nature Medicine.
[10] I. McInnes,et al. Disease-associated functions of IL-33: the new kid in the IL-1 family , 2010, Nature Reviews Immunology.
[11] J. Girard,et al. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1 , 2009, Proceedings of the National Academy of Sciences.
[12] J. Pollheimer,et al. Interleukin-33 - cytokine of dual function or novel alarmin? , 2009, Trends in immunology.
[13] C. Dinarello,et al. Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.
[14] M. Nolte,et al. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity , 2009, Immunological reviews.
[15] V. Appay,et al. Phenotype and function of human T lymphocyte subsets: Consensus and issues , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[16] J. Girard,et al. The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’? , 2008, PloS one.
[17] E. Wherry,et al. MyD88 Plays a Critical T Cell-Intrinsic Role in Supporting CD8 T Cell Expansion during Acute Lymphocytic Choriomeningitis Virus Infection1 , 2008, The Journal of Immunology.
[18] A. Rothman,et al. Elevated levels of soluble ST2 protein in dengue virus infected patients. , 2008, Cytokine.
[19] Scott N. Mueller,et al. Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection , 2007, Proceedings of the National Academy of Sciences.
[20] Nikhil S. Joshi,et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. , 2007, Immunity.
[21] Delphine A. Lacorre,et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo , 2007, Proceedings of the National Academy of Sciences.
[22] J Fernando Bazan,et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.
[23] J. Oppenheim,et al. Alarmins: chemotactic activators of immune responses. , 2005, Current opinion in immunology.
[24] J. Zúñiga-Pflücker,et al. Functional Requirements for Signaling through the Stimulatory and Inhibitory Mouse NKR-P1 (CD161) NK Cell Receptors1 , 2005, The Journal of Immunology.
[25] R. Nuñez,et al. C-type lectin OCILRP2/Clr-g and its ligand NKRP1f costimulate T cell proliferation and IL-2 production. , 2005, Cellular immunology.
[26] J. Yewdell,et al. Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design. , 2005, Annual review of immunology.
[27] R. Zinkernagel,et al. Kinetics of protective antibodies are determined by the viral surface antigen , 2004 .
[28] R. Dutton,et al. Tc1 and Tc2 Effector Cell Therapy Elicit Long-Term Tumor Immunity by Contrasting Mechanisms That Result in Complementary Endogenous Type 1 Antitumor Responses1 , 2004, The Journal of Immunology.
[29] P. Park,et al. Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential , 2003, The Journal of experimental medicine.
[30] A. Jegerlehner,et al. Critical Role for Activation of Antigen-Presenting Cells in Priming of Cytotoxic T Cell Responses After Vaccination with Virus-Like Particles1 , 2002, The Journal of Immunology.
[31] P. Matzinger,et al. Danger signals: SOS to the immune system. , 2001, Current opinion in immunology.
[32] U. Koszinowski,et al. Cloning and Mutagenesis of the Murine Gammaherpesvirus 68 Genome as an Infectious Bacterial Artificial Chromosome , 2000, Journal of Virology.
[33] T. Rülicke,et al. T1‐deficient and T1‐Fc‐transgenic mice develop a normal protective Th2‐type immune response following infection with Nippostrongylus brasiliensis , 2000, European journal of immunology.
[34] D. J. Matthews,et al. T1/St2-Deficient Mice Demonstrate the Importance of T1/St2 in Developing Primary T Helper Cell Type 2 Responses , 2000, The Journal of experimental medicine.
[35] J. Ashby. References and Notes , 1999 .
[36] Andreas Radbruch,et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[37] F. Liew,et al. Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells , 1998, The Journal of experimental medicine.
[38] A. Nash,et al. Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells , 1993, Journal of virology.
[39] R. Zinkernagel,et al. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression , 1991, The Journal of experimental medicine.
[40] M. Schilham,et al. Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4 , 1991, Nature.
[41] H. Pircher,et al. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen , 1989, Nature.
[42] B. Moss,et al. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype , 1985, Nature.